We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study.
- Authors
Izzedine, Hassane; Hulot, Jean Sebastien; Vittecoq, Daniel; Gallant, Joel E; Staszewski, Schlomo; Launay-Vacher, Vincent; Cheng, Andrew; Deray, Gilbert; Study 903 Team
- Abstract
Tenofovir disoproxil fumarate (TDF) was developed for the treatment of human immunodeficiency virus (HIV) infection. However, controlled data are sparse on the long-term renal tolerability of TDF at the currently approved daily dose of 300 mg in treatment-naive HIV-infected patients.
- Publication
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Vol 20, Issue 4, p743
- ISSN
0931-0509
- Publication type
Journal Article
- DOI
10.1093/ndt/gfh658